Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

por Wang-Gohrke, S, Weikel, W, Risch, H, Vesprini, D, Abrahamson, J, Lerman, C, Godwin, A, Moslehi, R, Olipade, O, Brunet, J-S, Stickeler, E, Kieback, D G, Kreienberg, R, Weber, B, Narod, S A, Runnebaum, I B
Publicado 1999